Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 45

1.

Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.

Trivedi PJ, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield GM, Weston CJ, Adams DH.

J Autoimmun. 2016 Apr;68:98-104. doi: 10.1016/j.jaut.2016.01.001. Epub 2016 Feb 9.

2.

CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions.

Li MQ, Wang Y, Chang KK, Meng YH, Liu LB, Mei J, Wang Y, Wang XQ, Jin LP, Li DJ.

Cell Death Dis. 2014 Oct 2;5:e1436. doi: 10.1038/cddis.2014.414.

3.

Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.

Chen HJ, Edwards R, Tucci S, Bu P, Milsom J, Lee S, Edelmann W, Gümüs ZH, Shen X, Lipkin S.

J Clin Invest. 2012 Sep;122(9):3184-96. doi: 10.1172/JCI62110. Epub 2012 Aug 6.

4.

Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.

Xu S, Menu E, De Becker A, Van Camp B, Vanderkerken K, Van Riet I.

Stem Cells. 2012 Feb;30(2):266-79. doi: 10.1002/stem.787.

5.

The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells.

Bowman EP, Kuklin NA, Youngman KR, Lazarus NH, Kunkel EJ, Pan J, Greenberg HB, Butcher EC.

J Exp Med. 2002 Jan 21;195(2):269-75.

6.

The human CC chemokine TECK (SCYA25) maps to chromosome 19p13.2.

Nomiyama H, Amano K, Kusuda J, Imai T, Miura R, Yoshie O, Matsuda Y.

Genomics. 1998 Jul 15;51(2):311-2. No abstract available.

PMID:
9722960
7.
8.

CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.

Zhang Z, Sun T, Chen Y, Gong S, Sun X, Zou F, Peng R.

DNA Cell Biol. 2016 Jul;35(7):348-57. doi: 10.1089/dna.2015.3104. Epub 2016 Mar 23.

PMID:
27008282
9.

CCR9 in cancer: oncogenic role and therapeutic targeting.

Tu Z, Xiao R, Xiong J, Tembo KM, Deng X, Xiong M, Liu P, Wang M, Zhang Q.

J Hematol Oncol. 2016 Feb 16;9:10. doi: 10.1186/s13045-016-0236-7. Review.

10.

Epigenetic characteristics in inflammatory candidate genes in aggressive periodontitis.

Schulz S, Immel UD, Just L, Schaller HG, Gläser C, Reichert S.

Hum Immunol. 2016 Jan;77(1):71-5. doi: 10.1016/j.humimm.2015.10.007. Epub 2015 Oct 21.

PMID:
26472015
11.

Intracellular expression profile and clinical significance of the CCR9-CCL25 chemokine receptor complex in nasopharyngeal carcinoma.

Ye LF, Huang J, Zhang LP, Chen Z.

J Laryngol Otol. 2015 Oct;129(10):1013-9. doi: 10.1017/S0022215115002108. Epub 2015 Aug 17.

PMID:
26279399
12.

CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.

Gupta P, Sharma PK, Mir H, Singh R, Singh N, Kloecker GH, Lillard JW Jr, Singh S.

Oncotarget. 2014 Oct 30;5(20):10170-9.

13.

CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.

Zhu S, Bing Y, Wang X, Yu Q, Wang Y, Xu S, Song L, Wang X, Xia B, Zhu Y, Zhou R.

PLoS One. 2014 Jun 17;9(6):e100167. doi: 10.1371/journal.pone.0100167. eCollection 2014.

14.

Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.

Singh R, Stockard CR, Grizzle WE, Lillard JW Jr, Singh S.

Int J Oncol. 2011 Aug;39(2):373-81. doi: 10.3892/ijo.2011.1059. Epub 2011 May 31.

15.

CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.

Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE, Lillard JW Jr.

Int J Oncol. 2011 May;38(5):1279-85. doi: 10.3892/ijo.2011.953. Epub 2011 Feb 23.

16.

Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.

Schmutz C, Cartwright A, Williams H, Haworth O, Williams JH, Filer A, Salmon M, Buckley CD, Middleton J.

Arthritis Res Ther. 2010;12(4):R161. doi: 10.1186/ar3120. Epub 2010 Aug 25.

17.
18.

Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC).

Sundström P, Lundin SB, Nilsson LA, Quiding-Järbrink M.

Eur J Immunol. 2008 Dec;38(12):3327-38. doi: 10.1002/eji.200838506. Erratum in: Eur J Immunol. 2009 Nov;39(11):3267.

19.

Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.

Amersi FF, Terando AM, Goto Y, Scolyer RA, Thompson JF, Tran AN, Faries MB, Morton DL, Hoon DS.

Clin Cancer Res. 2008 Feb 1;14(3):638-45. doi: 10.1158/1078-0432.CCR-07-2025. Erratum in: Clin Cancer Res. 2008 Mar 1;14(5):1598. Clin Cancer Res. 2008 May 1;14(9):2892.

20.

Intracellular signaling required for CCL25-stimulated T cell adhesion mediated by the integrin alpha4beta1.

Parmo-Cabañas M, García-Bernal D, García-Verdugo R, Kremer L, Márquez G, Teixidó J.

J Leukoc Biol. 2007 Aug;82(2):380-91. Epub 2007 May 17.

PMID:
17510295

Supplemental Content

Support Center